There are 3397 resources available
Connecting the dots: Understanding recent clinical evidence in the framework of previous studies and current practice
Presenter: Martin van den Bent
Session: Servier - Are brain cancer patients finally able to benefit from precision medicine approaches?
Resources:
Webcast
Next-Generation Antibody-Drug Conjugates in Practice: A Case-Based Discussion
Presenter: Sara Hurvitz
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Overview of current trials investigating first-line treatment of LA/mUC
Presenter: Terence Friedlander
Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC
Resources:
Webcast
Update on Immuno-Oncology for the Treatment of Gastric Cancer
Presenter: Tania Fleitas
Session: Bristol Myers Squibb - Immuno-Oncology Landscape for GI Cancers: Perspectives on Current Practices and Recent Advances
Resources:
Webcast
Exploring New Opportunities to Improve Outcomes in Patients with HER2+ mCRC
Presenter: Salvatore Siena
Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?
Resources:
Webcast
The evolving paradigm for clinical management of glioma
Presenter: Sara Erridge
Session: Servier - Are brain cancer patients finally able to benefit from precision medicine approaches?
Resources:
Webcast
Clinical experiences with first-line treatment of LA/mUC
Presenter: All Speakers
Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC
Resources:
Webcast
New Antibody-Drug Conjugates on the Horizon
Presenter: Peter Schmid
Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates
Resources:
Webcast
Advances in Immuno-Oncology for the Treatment of Colorectal Cancer
Presenter: Maria Elena Elez Fernandez
Session: Bristol Myers Squibb - Immuno-Oncology Landscape for GI Cancers: Perspectives on Current Practices and Recent Advances
Resources:
Webcast
Panel Discussion and Interactive Q&A
Presenter: All Speakers
Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?
Resources:
Webcast